Abstract 4487: Association of the tumor-immune microenvironment with response to niraparib and pembrolizumab in relapsed, platinum-resistant ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, Steven Waggoner et al.|Immunology|2019Cited by 0